Using global Nox4 knockout mice and cardiomyocyte‐specific transgenic (TG) mouse models, our previous studies showed that Nox4 is protective against cardiac hypertrophy, contractile dysfunction, and fibrosis in response to pressure overload or myocardial ischaemia. The gene discussed is NOX4; the disease is cardiac hypertrophy.